Circular RNA drives resistance to anti-PD-1 immunotherapy by regulating the miR-30a-5p/SOX4 axis in non-small cell lung cancer

Abstract

Aim: Circular RNAs are widely and abnormally expressed in human cancer cells, and they participate in cancer progression. However, they have rarely been investigated in the immune evasion of non-small cell lung cancer (NSCLC). Here, we elucidated the function and molecular mechanism of hsa_circ_0020714 in promoting the resistance to anti-PD-1 immunotherapy of NSCLC.

Methods: The expression of hsa_circ_0020714 were examined by qRT-PCR. In vivo experiments were executed to investigate the biological function of hsa_circ_0020714 in the sensitivity of NSCLC to anti-PD-1 immunotherapy. The qRT-PCR, fluorescence in situ hybridization, RNA pulldown, RNA immunoprecipitation, and western blot were carried out to investigate the potential regulatory mechanisms of hsa_circ_0020714 in NSCLC immune evasion.

Results: The expression of hsa_circ_0020714 was upregulated in NSCLC tissues compared to the paired adjacent non-tumor tissues, and an increased expression of hsa_circ_0020714 was significantly associated with a bad prognosis and resistance to anti-PD-1 immunotherapy in patients with NSCLC. Mechanistically, hsa_circ_0020714 functions as an endogenous miR-30a-5p sponge to enhance SOX4 expression, thereby promoting immune evasion and anti-PD-1 resistance in NSCLC patients.

Conclusion: Hsa_circ_0020714 induces the immune evasion and resistance to anti-PD-1 immunotherapy of NSCLC via the miR-30a-5p/SOX4 axis, and may be an promising immunotherapeutic target in NSCLC.

Keywords

NSCLC / immune evasion / circRNAs / PD-1 / immunotherapy resistance

References

[1] Wang M,Boshoff C.Toward personalized treatment approaches for non-small-cell lung cancer.Nat Med2021;27:1345-56

[2] Melosky B,Juergens RA.The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer.Lung Cancer2021;160:136-51

[3] Doroshow DB,Hastings K.Immunotherapy in non-small cell lung cancer: facts and hopes.Clin Cancer Res2019;25:4592-602 PMCID:PMC6679805

[4] Lee YJ,Ha SJ.Clinical perspectives to overcome acquired resistance to anti-programmed death-1 and anti-programmed death ligand-1 therapy in non-small cell lung cancer.Mol Cells2021;44:363-73 PMCID:PMC8175154

[5] Zhou WY,Liu J,Ju HQ.Circular RNA: metabolism, functions and interactions with proteins.Mol Cancer2020;19:172 PMCID:PMC7734744

[6] Ma S,Wang F.CircRNAs: biogenesis, functions, and role in drug-resistant Tumours.Mol Cancer2020;19:119 PMCID:PMC7409473

[7] Zhong Y,Yang X.Circular RNAs function as ceRNAs to regulate and control human cancer progression.Mol Cancer2018;17:79 PMCID:PMC5889847

[8] Zhang PF,Li KS.Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells.Mol Cancer2019;18:179 PMCID:PMC6900862

[9] Li B,Lu C.circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity.Nat Commun2021;12:295 PMCID:PMC7804955

[10] Pei X,Long X.circMET promotes NSCLC cell proliferation, metastasis, and immune evasion by regulating the miR-145-5p/CXCL3 axis.Aging (Albany NY)2020;12:13038-58 PMCID:PMC7377868

[11] Hanieh H,Vishnubalaji R.SOX4: epigenetic regulation and role in tumorigenesis.Semin Cancer Biol2020;67:91-104

[12] Moreno CS.SOX4: the unappreciated oncogene.Semin Cancer Biol2020;67:57-64 PMCID:PMC7043201

[13] Bagati A,Jiang P.Integrin αvβ6-TGFβ-SOX4 pathway drives immune evasion in triple-negative breast cancer.Cancer Cell2021;39:54-67.e9 PMCID:PMC7855651

[14] Huang XY,Wei CY.Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.Mol Cancer2020;19:92 PMCID:PMC7236145

[15] Zhang PF,Huang XY.Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.Mol Cancer2020;19:110 PMCID:PMC7320583

[16] Zhu J,Zhou J.CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.J Exp Clin Cancer Res2021;40:192 PMCID:PMC8191020

[17] Wei CY,Lu NH.Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma.Mol Cancer2020;19:84 PMCID:PMC7204052

[18] Tang Y,Jiang HM.The roles of circRNAs in liver cancer immunity.Front Oncol2020;10:598464 PMCID:PMC7890029

[19] Holdt LM,Sass K.Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans.Nat Commun2016;7:12429 PMCID:PMC4992165

[20] Liu L,Zhang Z.LncRNA PITPNA-AS1 promotes gastric cancer by increasing SOX4 expression via inhibition of miR-92a-3p.Aging (Albany NY)2021;13:21191-201 PMCID:PMC8457584

[21] Wang Q,Luo F.LINC00511 promotes gastric cancer progression by regulating SOX4 and epigenetically repressing PTEN to activate PI3K/AKT pathway.J Cell Mol Med2021;25:9112-27 PMCID:PMC8500959

[22] Luo Q,Fu Q.hsa_circ_0001018 promotes papillary thyroid cancer by facilitating cell survival, invasion, G1/S cell cycle progression, and repressing cell apoptosis via crosstalk with miR-338-3p and SOX4.Mol Ther Nucleic Acids2021;24:591-609 PMCID:PMC8054110

[23] Li F,Xuan Y.PD-1 abrogates the prolonged persistence of CD8⁺ CAR-T cells with 4-1BB co-stimulation.Signal Transduct Target Ther2020;5:164 PMCID:PMC7447768

[24] Li X,Xiang R.Clonal replacement of novel T cells: a new phenomenon in the tumor microenvironment following PD-1 blockade.Signal Transduct Target Ther2019;4:43 PMCID:PMC6813357